$100.8 M

GNPX Mkt cap, 12-Nov-2021
Genprex Net income (FY, 2020)-17.9 M
Genprex EBIT (FY, 2020)-18 M
Genprex Cash, 31-Dec-202027.3 M
Get notified regarding key financial metrics and revenue changes at GenprexLearn more
Banner background

Genprex Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

R&D expense

289.9k971.4k2.0m7.3m

General and administrative expense

3.0m11.4m8.7m10.6m

Operating expense total

3.3m12.4m10.7m17.9m

Depreciation and amortization

3.2k5.9k13.1k22.8k

EBIT

(3.3m)(12.4m)(10.7m)(18.0m)

Interest expense

1.9k38.0k

Interest income

80.029.2k27.9k18.8k

Net Income

(3.3m)(12.4m)(10.7m)(17.9m)

EPS

(0.3)(0.9)(0.7)

Genprex Balance Sheet

Genprex Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(3.3m)(12.4m)(10.7m)(17.9m)

Depreciation and Amortization

3.2k5.9k13.1k22.8k

Accounts Receivable

(663.0)(453.0)8.6k528.0

Accounts Payable

545.3k(443.1k)141.2k(247.3k)

Cash From Operating Activities

(2.2m)(6.8m)(6.9m)(13.9m)

Purchases of PP&E

(5.9k)(22.4k)(33.4k)(17.6k)

Cash From Investing Activities

(63.4k)(103.3k)(946.9k)(2.3m)

Cash From Financing Activities

794.0k15.4m1.3m41.6m

Net Change in Cash

(1.4m)8.4m(6.6m)25.3m

Genprex Ratios

USDFY, 2017

Financial Leverage

2.9 x

Genprex Operating Metrics

Feb, 2014Q2, 2017

Patent Applications

2

Patents Issued

30

Phase I Patients Enrolled

5728